HKD 33.3
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 676.04 Million CNY | 113.55% |
2022 | 268.87 Million CNY | -46.54% |
2021 | 587.99 Million CNY | 30.0% |
2020 | 403.94 Million CNY | 984.36% |
2019 | 216.81 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q3 | 193.69 Million CNY | 264.93% |
2023 Q1 | 53.07 Million CNY | 91.81% |
2023 Q4 | 193.69 Million CNY | 0.0% |
2023 FY | - CNY | 113.55% |
2023 Q2 | 53.07 Million CNY | 0.0% |
2022 Q4 | 27.67 Million CNY | 0.0% |
2022 FY | - CNY | -46.54% |
2022 Q3 | 27.67 Million CNY | 0.0% |
2021 FY | - CNY | 30.0% |
2020 FY | - CNY | 984.36% |
2019 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 22.91 Million HKD | -2850.594% |
Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | -112.762% |
China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -33218.876% |
Prosperous Future Holdings Limited | -19.68 Million HKD | 3534.116% |
Huasheng International Holding Limited | 19.67 Million HKD | -3335.512% |
Fourace Industries Group Holdings Limited | 61.52 Million HKD | -998.805% |
Evergreen Products Group Limited | 140.78 Million HKD | -380.203% |
EC Healthcare | 737.83 Million HKD | 8.375% |
Ming Fai International Holdings Limited | 211.83 Million HKD | -219.137% |
Blue Moon Group Holdings Limited | 656.37 Million HKD | -2.996% |
SuperRobotics Holdings Limited | -7.39 Million HKD | 9236.912% |
Takbo Group Holdings Limited | 25.8 Million HKD | -2519.904% |
Hyfusin Group Holdings Limited | 154.18 Million HKD | -338.455% |